NEOMYCIN SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for neomycin sulfate and what is the scope of freedom to operate?
Neomycin sulfate
is the generic ingredient in thirteen branded drugs marketed by Pharmacia And Upjohn, X Gen Pharms, Pfizer, Adrastea Pharma, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Nostrum Labs Inc, Roxane, Sandoz, Teva, Glaxosmithkline, Alcon, Watson Labs, Xgen Pharms, Monarch Pharms, Allergan, Merck, Savage Labs, Fougera, and Pharmaderm, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.There are thirteen drug master file entries for neomycin sulfate. Four suppliers are listed for this compound.
Summary for NEOMYCIN SULFATE
US Patents: | 0 |
Tradenames: | 13 |
Applicants: | 22 |
NDAs: | 31 |
Drug Master File Entries: | 13 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 99 |
Clinical Trials: | 11 |
Patent Applications: | 7,004 |
What excipients (inactive ingredients) are in NEOMYCIN SULFATE? | NEOMYCIN SULFATE excipients list |
DailyMed Link: | NEOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for NEOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vietstar Biomedical Research | N/A |
Huro Biotech Joint Stock Company | N/A |
Mahidol University | Phase 4 |
Pharmacology for NEOMYCIN SULFATE
Drug Class | Aminoglycoside Antibacterial |
Medical Subject Heading (MeSH) Categories for NEOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for NEOMYCIN SULFATE
US Patents and Regulatory Information for NEOMYCIN SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | STATROL | neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 050344-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Glaxosmithkline | NEOSPORIN | neomycin sulfate; polymyxin b sulfate | CREAM;TOPICAL | 050176-002 | Jan 14, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Pfizer | NEOBIOTIC | neomycin sulfate | TABLET;ORAL | 060475-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Monarch Pharms | NEOSPORIN G.U. IRRIGANT | neomycin sulfate; polymyxin b sulfate | SOLUTION;IRRIGATION | 060707-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Teva | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 060304-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Merck | NEO-HYDELTRASOL | neomycin sulfate; prednisolone sodium phosphate | OINTMENT;OPHTHALMIC | 050378-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
NEOMYCIN SULFATE Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.